HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
Ann. Oncol., Available online 19 April 2020 | https://doi.org/10.1016/j.annonc.2020.04.004